[Glycosphingolipids from human T-lymphoma MOLT-4 cells]. 1987

E V Fomina-Ageeva, and E V Diatlovitskaia, and A F Lemenovskaia, and L D Bergel'son

The glycosphingolipids of human lymphoma MOLT-4 cells were studied, using biochemical methods and specific antisera to gangliosides. The major neutral glycosphingolipids were found to be glucosyl- and lactosyl ceramides. GM3, GM2, GM1 and GD1a were identified as ganglioside components.

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D005732 Gangliosides A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) Ganglioside,Sialoglycosphingolipids
D006028 Glycosphingolipids Lipids containing at least one monosaccharide residue and either a sphingoid or a ceramide (CERAMIDES). They are subdivided into NEUTRAL GLYCOSPHINGOLIPIDS comprising monoglycosyl- and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides; and ACIDIC GLYCOSPHINGOLIPIDS which comprises sialosylglycosylsphingolipids (GANGLIOSIDES); SULFOGLYCOSPHINGOLIPIDS (formerly known as sulfatides), glycuronoglycosphingolipids, and phospho- and phosphonoglycosphingolipids. (From IUPAC's webpage) Asialoganglioside,Asialogangliosides,Glycosphingolipid,Sphingoglycolipid,Sphingoglycolipids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

E V Fomina-Ageeva, and E V Diatlovitskaia, and A F Lemenovskaia, and L D Bergel'son
January 2000, Anticancer research,
E V Fomina-Ageeva, and E V Diatlovitskaia, and A F Lemenovskaia, and L D Bergel'son
March 1992, The Journal of laboratory and clinical medicine,
E V Fomina-Ageeva, and E V Diatlovitskaia, and A F Lemenovskaia, and L D Bergel'son
January 1975, Immunological communications,
E V Fomina-Ageeva, and E V Diatlovitskaia, and A F Lemenovskaia, and L D Bergel'son
December 2007, Biochemical pharmacology,
E V Fomina-Ageeva, and E V Diatlovitskaia, and A F Lemenovskaia, and L D Bergel'son
May 1985, Biochimica et biophysica acta,
E V Fomina-Ageeva, and E V Diatlovitskaia, and A F Lemenovskaia, and L D Bergel'son
January 1990, Biology of the cell,
E V Fomina-Ageeva, and E V Diatlovitskaia, and A F Lemenovskaia, and L D Bergel'son
January 2007, Acta biochimica Polonica,
E V Fomina-Ageeva, and E V Diatlovitskaia, and A F Lemenovskaia, and L D Bergel'son
August 1974, The Journal of experimental medicine,
E V Fomina-Ageeva, and E V Diatlovitskaia, and A F Lemenovskaia, and L D Bergel'son
February 2003, Cancer chemotherapy and pharmacology,
E V Fomina-Ageeva, and E V Diatlovitskaia, and A F Lemenovskaia, and L D Bergel'son
April 2016, Biochemical and biophysical research communications,
Copied contents to your clipboard!